Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Magic Mushroom Drug Helps Cancer Patients Chill Out

Duration: 00:54s - Published: < > Embed
News video: Magic Mushroom Drug Helps Cancer Patients Chill OutThe "magic mushroom" drug psilocybin can help cancer patients relax and feel less distressed about their disease, two teams of doctors reported Thursday. The drug eased anxiety and depression in 80 percent of the patients who took it in the studies, and many described their one-time sessions as ranking among the most meaningful experiences of their lives. Dr. Stephen Ross, director of addiction psychiatry at New York University's Langone Medical Center, gave the following statement to NBC news.

0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

CytRx surges after being invited to present at prestigious cancer conference

Shares in cancer treatment specialist CytRx Corporation (NASDAQ:CYTR) surged as it said it would...
Proactive Investors - Business

Eli Lilly reports endpoint success in advanced breast cancer trial

Eli Lilly & Co (NYSE:LLY) has reported improved survival rates in advanced breast cancer patients...
Proactive Investors - Business

Drug created from malaria parasite shows promise as bladder cancer treatment

A drug created from a malaria protein stopped tumor growth of chemotherapy-resistant bladder cancer,...
Science Daily - Science

High rate of tumor shrinkage among pancreatic cancer patients

Adding cisplatin to standard gemcitabine/nab-paclitaxel drug treatment provided a very high rate of...
Science Daily - Science

TheraLase Technologies treats third patient with lead cancer compound

TheraLase Technologies Inc (CVE:TLT, OTCMKTS:TLTFF) told investors a third patient had been treated...
Proactive Investors - Business

Syros to Present on Its Pioneering Approach to Identify Novel Drug Targets Linked to Genomically Defined Subsets of Patients at IMPAKT Breast Cancer Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company...
Business Wire - Press Releases

India's antitrust watchdog orders probe into Roche cancer drug

MUMBAI (Reuters) - India's antitrust regulator has ordered a probe into Swiss drugmaker Roche for...
Reuters India - Front Page

Treatment improved overall survival in elderly patients with early-stage esophageal cancer

Elderly patients with early-stage esophageal cancer that received treatment had an increased 5-year...
Science Daily - Science

The Medicines Company granted approval for phase III trial of new heart drug

The Medicines Company (NASDAQ:MDCO) and partner Alnylam Pharmaceuticals Inc (LON:ALNY) have agreed...
Proactive Investors - Business

Agios bags $250M in offering as cancer drug speeds toward approval

Agios Pharmaceuticals has raised $250 million in a new stock offering as the Cambridge cancer biotech...
bizjournals - Business


You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+